fda warning letters glp-1 september 2025 Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded medications. Read more at the link in the comments below FDA Moves to Restrict Mass-Marketed

The most concerning effects of using Tylenol are liver damage and glutathione depletion

Kamarzaman S, Shaban M, AbdulRahman S

Acute pancreatitis in patients after bariatric surgery: incidence, outcomes and risk factors

For help, email [email protected]

In HIV-associated lipodystrophy, daily tesamorelin significantly reduces visceral adipose tissue and improves lipid profiles over 612 months [3] [4]

What the Research Says About GLP-1s and HS While clinical research is still in early stages, several studies support what many of us in the HS community have seen anecdotally: A 2024 study of patients with HS found that semaglutide reduced the frequency of flares and systemic inflammationflaring decreased from once every 8.5 weeks to once every 12 weeks